Latest articles on Biovac Institute

Q&A Sessions: ‘My north star is the patient’

Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it

vital information

The Mail & Guardian’s essential coverage of the ongoing coronavirus crisis is free to read for everyone.

If you would like to support us, please consider taking out a subscription.

Latest

Soup for the Sick: A bowl of warmth in a time of need

Soup for the Sick is nourishing hundreds of people too ill to cook for themselves

Q&A Sessions: George Euvrard, the brains behind our cryptic crossword

George Euvrard spoke to Athandiwe Saba about his passion for education, clues on how to solve his crosswords and the importance of celebrating South Africa.

Why prisoners are a priority in vaccine rollout

Inmates comprise a vulnerable group in society and they are meant to receive Covid-19 vaccines earlier than the general population. This has sparked debate locally and globally

Press Releases